Malaque, Via Rose .
HRN: 25-95-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2024
CEFUROXIME 1.5GM (VIAL)
12/14/2024
12/15/2024
IV
1.5g
Q8hrs
Post-op Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes